Skip to main content
. 2023 Jul 4;14:1199383. doi: 10.3389/fmicb.2023.1199383

Table 2.

Anthropometric, biochemical, and cardiometabolic biomarkers of overweight women at baseline and at 2-week and 4-week time points during the intake of blood orange juice.

Variables Baseline 2 weeks 4 weeks Value of p
Body weight (kg) 73.65 ± 6.36 73.88 ± 6.37 73.99 ± 6.69 0.722
BMI (kg/m2) 27.86 ± 0.41 27.95 ± 0.45 27.99 ± 0.52 0.938
Abdominal circumference (cm) 90.00 ± 1.55 88.75 ± 1.50 88.92 ± 1.51 0.741
Blood pressure (mmHg)
Systolic 118.67 ± 2.55 113.92 ± 3.93 113.83 ± 4.42 0.338
Diastolic 73.08 ± 2.35 a 69.25 ± 2.77 b 69.25 ± 1.89 b 0.020
Glucose (mg/dL) 79.58 ± 3.36 75.08 ± 2.40 74.75 ± 3.36 0.537
Insulin (μUI/mL) 17.05 ± 1.96 15.25 ± 1.37 14.21 ± 1.22 0.558
HOMA-IR 3.43 ± 0.52 2.83 ± 0.27 2.56 ± 0.17 0.338
Cholesterol (mg/dL)
HDL 50.08 ± 4.39 47.75 ± 3.42 49.83 ± 4.44 0.112
LDL 70.83 ± 6.97 76.17 ± 8.03 78.50 ± 6.36 0.338
Total 138.42 ± 9.32 144.08 ± 9.77 150.50 ± 9.02 0.717
Triglycerides (mg/dL) 88.00 ± 10.91 100.67 ± 13.67 104.75 ± 15.31 0.205
C-reactive protein (mg/dL) 2.23 ± 0.38 2.84 ± 0.57 2.20 ± 0.49 0.405
TNF-α (pg/mL) 3.10 ± 0.12 3.12 ± 0.13 3.10 ± 0.12 0.723
IL-6 (pg/mL) 3.95 ± 0.67 3.96 ± 0.72 4.15 ± 0.76 0.236
IL-10 (pg/mL) 3.83 ± 0.19 3.88 ± 0.23 3.92 ± 0.18 0.976
VCAM-1 (ng/mL) 554.99 ± 15.63 a 553.62 ± 14.31 ab 545.31 ± 14.65 b 0.039
ICAM-1 (ng/mL) 367.57 ± 25.73 353.73 ± 28.89 349.34 ± 27.69 0.920
Fibrinogen (mg/dL) 301.17 ± 23.91 273.33 ± 21.25 297.75 ± 26.81 0.205
LPS (EU/mL) 0.07 ± 0.00 0.08 ± 0.01 0.07 ± 0.00 0.875

BMI, body mass index; HOMA-IR, Homeostasis model assessment for insulin resistance; HDL, high-density lipoprotein; LDL, low-density lipoprotein; TNF-α, tumor necrosis factor-alpha; IL, interleukin; VCAM-1, vascular cellular adhesion molecule 1; ICAM-1, intercellular adhesion molecule 1; LPS, lipopolysaccharide. The p-values were calculated using the Friedman test. Values in bold and different superscript letters indicate statistical significance (p < 0.05) among values (n = 12) obtained in the baseline and after 2 and 4 weeks of blood orange juice intake.